118 related articles for article (PubMed ID: 35997145)
1. Irritable bowel syndrome following COVID-19: an underestimated consequence of SARS-CoV-2 infection.
Nazarewska A; Lewandowski K; Kaniewska M; Rosołowski M; Marlicz W; Rydzewska G
Pol Arch Intern Med; 2022 Nov; 132(11):. PubMed ID: 35997145
[TBL] [Abstract][Full Text] [Related]
2. Persisting gastrointestinal symptoms and post-infectious irritable bowel syndrome following SARS-CoV-2 infection: results from the Arizona CoVHORT.
Austhof E; Bell ML; Riddle MS; Catalfamo C; McFadden C; Cooper K; Scallan Walter E; Jacobs E; Pogreba-Brown K
Epidemiol Infect; 2022 Jul; 150():e136. PubMed ID: 35801302
[TBL] [Abstract][Full Text] [Related]
3. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
Su AM; Shih W; Presson AP; Chang L
Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
[TBL] [Abstract][Full Text] [Related]
4. Development of functional diarrhea, constipation, irritable bowel syndrome, and dyspepsia during and after traveling outside the USA.
Tuteja AK; Talley NJ; Gelman SS; Alder SC; Thompson C; Tolman K; Hale DC
Dig Dis Sci; 2008 Jan; 53(1):271-6. PubMed ID: 17549631
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria.
Black CJ; Yiannakou Y; Houghton LA; Ford AC
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):392-398.e2. PubMed ID: 31154027
[TBL] [Abstract][Full Text] [Related]
6. Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities.
Black CJ; Houghton LA; Ford AC
Neurogastroenterol Motil; 2022 Nov; 34(11):e14391. PubMed ID: 35531932
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
Goodoory VC; Houghton LA; Black CJ; Ford AC
Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
[TBL] [Abstract][Full Text] [Related]
8. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Yield of Colonoscopy in Patients With Symptoms Compatible With Rome IV Functional Bowel Disorders.
Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; David Tai FW; Afify S; Aziz I
Clin Gastroenterol Hepatol; 2022 Feb; 20(2):334-341.e3. PubMed ID: 32882424
[TBL] [Abstract][Full Text] [Related]
10. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
Schurman JV; Karazsia BT; Friesen CA
Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of organic disease at colonoscopy in patients with symptoms compatible with irritable bowel syndrome: cross-sectional survey.
Patel P; Bercik P; Morgan DG; Bolino C; Pintos-Sanchez MI; Moayyedi P; Ford AC
Scand J Gastroenterol; 2015 Jul; 50(7):816-23. PubMed ID: 25636675
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Rome IV Functional Bowel Disorders Among Adults in the United States, Canada, and the United Kingdom.
Palsson OS; Whitehead W; Törnblom H; Sperber AD; Simren M
Gastroenterology; 2020 Apr; 158(5):1262-1273.e3. PubMed ID: 31917991
[TBL] [Abstract][Full Text] [Related]
13. Prolonged Gastrointestinal Manifestations After Recovery From COVID-19.
Elmunzer BJ; Palsson OS; Forbes N; Zakaria A; Davis C; Canakis A; Qayed E; Bick B; Pawa S; Tierney WM; McLeod CG; Taylor J; Patel H; Mendelsohn RB; Bala G; Sloan I; Merchant AA; Smith ZL; Sendzischew Shane MA; Aroniadis OC; Ordiah CO; Ruddy JM; Simren M; Tack J; Drossman D;
Clin Gastroenterol Hepatol; 2024 May; 22(5):1098-1107.e3. PubMed ID: 37995983
[TBL] [Abstract][Full Text] [Related]
14. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.
Ghoshal UC; Abraham P; Bhatia SJ; Misra SP; Choudhuri G; Biswas KD; Chakravartty K; Dadhich S; Goswami BD; Jayanthi V; Kumar S; Koshy A; Kumar KR; Makharia G; Nijhawan S; Pratap N; Ray G; Sachdeva S; Singh SP; Thomas V; Udawat H
Indian J Gastroenterol; 2013 Nov; 32(6):369-75. PubMed ID: 23999682
[TBL] [Abstract][Full Text] [Related]
16. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
[TBL] [Abstract][Full Text] [Related]
17. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care.
Black CJ; Craig O; Gracie DJ; Ford AC
Gut; 2021 Jun; 70(6):1110-1116. PubMed ID: 32973070
[TBL] [Abstract][Full Text] [Related]
19. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
[TBL] [Abstract][Full Text] [Related]
20. Incidence and predisposing factors for de novo post-COVID-19 irritable bowel syndrome.
Siyal M; Abbas Z; Ashraf J; Ali Qadeer M; Altaf A
Eur J Gastroenterol Hepatol; 2023 Jan; 35(1):59-63. PubMed ID: 36468570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
